Research Output 1965 2020

Filter
Article
Article
14 Citations (Scopus)

A Phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignancies

Heath, E. I., LoRusso, P., Ramalingam, S. S., Awada, A., Egorin, M. J., Besse-Hamer, T., Cardoso, F., Valdivieso, M., Has, T., Alland, L., Zhou, X. & Belani, C., Dec 1 2011, In : Investigational New Drugs. 29, 6, p. 1426-1431 6 p.

Research output: Contribution to journalArticle

Paclitaxel
Appointments and Schedules
Neoplasms
Sepsis
Constipation
9 Citations (Scopus)

A phase 1 study of fixed dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer

Sun, W., Hewitt, M. R., Theobald, M. R., Hershock, D. & Haller, D. G., Dec 15 2007, In : Cancer. 110, 12, p. 2768-2774 7 p.

Research output: Contribution to journalArticle

irinotecan
gemcitabine
Biliary Tract Neoplasms
Pancreatic Neoplasms
Maximum Tolerated Dose
1 Citation (Scopus)

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma

Voss, M. H., Bhatt, R. S., Vogelzang, N. J., Fishman, M., Alter, R. S., Rini, B. I., Beck, J. T., Joshi, M., Hauke, R., Atkins, M. B., Burgess, E., Logan, T. F., Shaffer, D., Parikh, R., Moazzam, N., Zhang, X., Glasser, C., Sherman, M. L. & Plimack, E. R., Jul 15 2019, In : Cancer. 125, 14, p. 2400-2408 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Placebos
Disease-Free Survival
axitinib
Human ALK1-Fc fusion protein
42 Citations (Scopus)

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients

Messing, E., Gee, J. R., Saltzstein, D. R., Kim, K. M., DiSant'Agnese, A., Kolesar, J., Harris, L., Faerber, A., Havighurst, T., Young, J. M., Efros, M., Getzenberg, R. H., Wheeler, M. A., Tangrea, J., Parnes, H., House, M., Busby, J. E., Hohl, R. & Bailey, H., Apr 1 2012, In : Cancer Prevention Research. 5, 4, p. 621-630 10 p.

Research output: Contribution to journalArticle

Isoflavones
Genistein
Chemoprevention
Tumor Biomarkers
Urinary Bladder Neoplasms

A phase-I, dose escalation study for salvage chemotherapy for patients with refractory lymphoma, prior to myeloablative therapy with stem cell transplantation

Choon-Kee, L., De Magalhaes-Silverman, M., Hohl, R., Hayashi, M., Schlueter, A. & Gingrich, R. D., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Salvaging
Transplants
Chemotherapy
Stem Cell Transplantation
Mitoxantrone
18 Citations (Scopus)

A phase I/pilot study of sequential doxorubicin/vinorelbine: Effects on p53 and microtubule-associated protein 4

Bash-Babula, J., Toppmeyer, D., Labassi, M., Reidy, J., Orlick, M., Senzon, R., Alli, E., Kearney, T., August, D., Shih, W., Yang, J-M. & Hait, W. N., 2002, In : Clinical Cancer Research. 8, 5, p. 1057-1064 8 p.

Research output: Contribution to journalArticle

Doxorubicin
Blood Cells
Microtubules
Polymerization
Therapeutics
70 Citations (Scopus)

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863

Venook, A. P., Klein, C. E., Fleming, G., Hollis, D., Leichman, C. G., Hohl, R., Byrd, J., Budman, D., Villalona, M., Marshall, J., Rosner, G. L., Ramirez, J., Kastrissios, H. & Ratain, M. J., Dec 1 2003, In : Annals of Oncology. 14, 12, p. 1783-1790 8 p.

Research output: Contribution to journalArticle

irinotecan
Pharmacokinetics
Radiation
Kidney
Liver
20 Citations (Scopus)

A phase I and pharmacokinetic study of oral 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A California Cancer Consortium Study

Chao, J., Synold, T. W., Morgan, R. J., Kunos, C., Longmate, J., Lenz, H. J., Lim, D., Shibata, S., Chung, V., Stoller, R. G., Belani, C., Gandara, D. R., McNamara, M., Gitlitz, B. J., Lau, D. H., Ramalingam, S. S., Davies, A., Espinoza-Delgado, I., Newman, E. M. & Yen, Y., Mar 1 2012, In : Cancer Chemotherapy and Pharmacology. 69, 3, p. 835-843 9 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Toxicity
Tumors
Maximum Tolerated Dose
Neoplasms
657 Citations (Scopus)

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B., Mineishi, S., Tarassoff, P., Satterlee, W., Raber, M. N. & Plunkett, W., Jan 1 1991, In : Journal of Clinical Oncology. 9, 3, p. 491-498 8 p.

Research output: Contribution to journalArticle

gemcitabine
Deamination
Pharmacology
Deoxycytidine
Phase II Clinical Trials
64 Citations (Scopus)

A phase II study of ABT-751 in patients with advanced non-small cell lung cancer

Mauer, A. M., Cohen, E. E. W., Ma, P. C., Kozloff, M. F., Schwartzberg, L., Coates, A. I., Qian, J., Hagey, A. E. & Gordon, G. B., Jun 2008, In : Journal of Thoracic Oncology. 3, 6, p. 631-636 6 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Antimitotic Agents
Survival
Cytotoxins
Constipation
27 Citations (Scopus)

A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: A California cancer consortium trial

Gitlitz, B. J., Tsao-Wei, D. D., Groshen, S., Davies, A., Koczywas, M., Belani, C. P., Argiris, A., Ramalingam, S., Vokes, E. E., Edelman, M., Hoffman, P., Ballas, M. S., Liu, S. V. & Gandara, D. R., Mar 2012, In : Journal of Thoracic Oncology. 7, 3, p. 574-578 5 p.

Research output: Contribution to journalArticle

eribulin
Non-Small Cell Lung Carcinoma
Neoplasms
Disease-Free Survival
Survival
175 Citations (Scopus)

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., MacK, P. C., Lurje, G., Gandour-Edwards, R., Dancey, J. & Gandara, D. R., Sep 1 2009, In : Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

Research output: Contribution to journalArticle

Biliary Tract
Liver Neoplasms
Disease-Free Survival
Neoplasms
Skin
9 Citations (Scopus)

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596); A trial of the eastern cooperative oncology group

Horn, L., Bernardo, P., Sandler, A., Wagner Jr., H., Levitan, N., Levitt, M. L. & Johnson, D. H., Jan 1 2009, In : Journal of Thoracic Oncology. 4, 4, p. 527-533 7 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Etoposide
Radiotherapy
Paclitaxel
Cisplatin
7 Citations (Scopus)

A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal carcinoma

Lowy, A. M., Firdaus, I., Roychowdhury, D., Redmond, K., Howington, J. A., Sussman, J. J., Safa, M., Ahmad, S. A., Reed, M. F., Rose, P., James, L. & Jazieh, A. R., Dec 1 2006, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 29, 6, p. 555-561 7 p.

Research output: Contribution to journalArticle

gemcitabine
Paclitaxel
Fluorouracil
Cisplatin
Radiotherapy
782 Citations (Scopus)

A phase II study of temozolemide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Yung, W. K. A., Albright, R. E., Olson, J., Fredericks, R., Fink, K., Prados, M. D., Brada, M., Spence, A., Hohl, R., Shapiro, W., Glantz, M., Greenberg, H., Selker, R. G., Vick, N. A., Rampling, R., Friedman, H., Phillips, P., Bruner, J., Yue, N., Osoba, D. & 2 others, Zaknoen, S. & Levin, V. A., Aug 31 2000, In : British Journal of Cancer. 83, 5, p. 588-593 6 p.

Research output: Contribution to journalArticle

temozolomide
Procarbazine
Glioblastoma
Recurrence
Disease-Free Survival
12 Citations (Scopus)

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402

Witzig, T. E., Hong, F., Micallef, I. N., Gascoyne, R. D., Dogan, A., Wagner Jr., H., Kahl, B. S., Advani, R. H. & Horning, S. J., Sep 1 2015, In : British Journal of Haematology. 170, 5, p. 679-686 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Vincristine
B-Cell Lymphoma
Prednisone
Non-Hodgkin's Lymphoma
17 Citations (Scopus)

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

Odia, Y., Kreisl, T. N., Aregawi, D., Innis, E. K. & Fine, H. A., Oct 1 2015, In : Journal of neuro-oncology. 125, 1, p. 191-195 5 p.

Research output: Contribution to journalArticle

Tamoxifen
Glioma
Medical Futility
Hypophosphatemia
Karnofsky Performance Status
58 Citations (Scopus)

A phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors

Ramanathan, R. K., Kirkpatrick, D. L., Belani, C. P., Friedland, D., Green, S. B., Chow, H. H. S., Cordova, C. A., Stratton, S. P., Shadow, E. R., Baker, A. & Dragovich, T., Apr 1 2007, In : Clinical Cancer Research. 13, 7, p. 2109-2114 6 p.

Research output: Contribution to journalArticle

Thioredoxins
Pharmacokinetics
Neoplasms
Pneumonia
Appointments and Schedules

A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U., Goel, S., O'Bryant, C. L., El-Rayes, B. F., Chung, V., Lenz, H. J., Kim, R., Belani, C. P., Tuscano, J. M., Schelman, W., Moore, N. & 2 others, Doroshow, J. H. & Chen, A. P., Nov 1 2019, In : British Journal of Clinical Pharmacology. 85, 11, p. 2499-2511 13 p.

Research output: Contribution to journalArticle

Open Access
Liver Diseases
Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
Liver
56 Citations (Scopus)

A phase I study of 17-Allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies

Ramalingam, S. S., Egorin, M. J., Ramanathan, R. K., Remick, S. C., Sikorski, R. P., Lagattuta, T. F., Chatta, G. S., Friedland, D. M., Stoller, R. G., Potter, D. M., Ivy, S. P. & Belani, C., Jun 1 2008, In : Clinical Cancer Research. 14, 11, p. 3456-3461 6 p.

Research output: Contribution to journalArticle

tanespimycin
Paclitaxel
Neoplasms
Pharmacokinetics
HSP90 Heat-Shock Proteins
27 Citations (Scopus)

A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors

Britten, C. D., Garrett-Mayer, E., Chin, S. H., Shirai, K., Ogretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S. L., Maines, L. W., Zhuang, Y., Smith, C. & Thomas, M. B., Aug 15 2017, In : Clinical Cancer Research. 23, 16, p. 4642-4650 9 p.

Research output: Contribution to journalArticle

Neoplasms
Sphingolipids
Drug-Related Side Effects and Adverse Reactions
Nausea
Vomiting
34 Citations (Scopus)

A phase i study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer

Tarhini, A. A., Belani, C. P., Luketich, J. D., Argiris, A., Ramalingam, S. S., Gooding, W., Pennathur, A., Petro, D., Kane, K., Liggitt, D., Championsmith, T., Zhang, X., Epperly, M. W. & Greenberger, J. S., Mar 1 2011, In : Human Gene Therapy. 22, 3, p. 336-342 7 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Non-Small Cell Lung Carcinoma
Liposomes
Superoxide Dismutase
2 Citations (Scopus)

A phase I study of DMS612, a novel bifunctional alkylating agent

Appleman, L. J., Balasubramaniam, S., Parise, R. A., Bryla, C., Redon, C. E., Nakamura, A. J., Bonner, W. M., Wright, J. J., Piekarz, R., Kohler, D. R., Jiang, Y., Belani, C. P., Eiseman, J., Chu, E., Beumer, J. H. & Bates, S. E., Feb 15 2015, In : Clinical Cancer Research. 21, 4, p. 721-729 9 p.

Research output: Contribution to journalArticle

NSC281612
Alkylating Agents
Maximum Tolerated Dose
Renal Cell Carcinoma
Fluorescent Antibody Technique
33 Citations (Scopus)

A phase I study of SPI-077 (Stealth® liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer

Rosenthal, D. I., Yom, S. S., Liu, L., Machtay, M., Algazy, K., Weber, R. S., Weinstein, G. S., Chalian, A. A., Miller, L. K., Rockwell, K., Tonda, M., Schnipper, E. & Hershock, D., Aug 8 2002, In : Investigational New Drugs. 20, 3, p. 343-349 7 p.

Research output: Contribution to journalArticle

Head and Neck Neoplasms
Radiotherapy
Cisplatin
Radiation
Transaminases
132 Citations (Scopus)

A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas

Kummar, S., Ji, J., Morgan, R., Lenz, H. J., Puhalla, S. L., Belani, C. P., Gandara, D. R., Allen, D., Kiesel, B., Beumer, J. H., Newman, E. M., Rubinstein, L., Chen, A., Zhang, Y., Wang, L., Kinders, R. J., Parchment, R. E., Tomaszewski, J. E. & Doroshow, J. H., Mar 15 2012, In : Clinical Cancer Research. 18, 6, p. 1726-1734 9 p.

Research output: Contribution to journalArticle

Cyclophosphamide
Lymphoma
Neoplasms
Maximum Tolerated Dose
Triple Negative Breast Neoplasms
22 Citations (Scopus)

A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days

Bailey, H. H., Wilding, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Simon, K., Marnocha, R., Holstein, S. A., Stewart, J., Lewis, K. A. & Hohl, R., Oct 1 2004, In : Cancer Chemotherapy and Pharmacology. 54, 4, p. 368-376 9 p.

Research output: Contribution to journalArticle

perilla alcohol
Transforming Growth Factors
Pharmacokinetics
Toxicity
Plasmas
2 Citations (Scopus)

A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors

Liu, S. V., Groshen, S. G., Kelly, K., Reckamp, K. L., Belani, C., Synold, T. W., Goldkorn, A., Gitlitz, B. J., Cristea, M. C., Gong, I. Y., Semrad, T. J., Xu, Y., Xu, T., Koczywas, M., Gandara, D. R. & Newman, E. M., Oct 1 2018, In : Cancer Chemotherapy and Pharmacology. 82, 4, p. 723-732 10 p.

Research output: Contribution to journalArticle

Topotecan
Tumors
Circulating Neoplastic Cells
Neoplasms
Phosphorylation
3 Citations (Scopus)

A phase i trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies

Chow, L. Q. M., Jonker, D. I., Dy, G. K., Nicholas, G., Fortin, C., Patricia, D., Adjei, A. A., Belani, C., Gupta, A., Park, J. S., Zhang, S., Sbar, E. I. & Laurie, S. A., May 1 2013, In : Cancer Chemotherapy and Pharmacology. 71, 5, p. 1273-1285 13 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Pharmacokinetics
Carboplatin
Paclitaxel
Safety
11 Citations (Scopus)

A Phosphomimetic Mutation Stabilizes SOD1 and Rescues Cell Viability in the Context of an ALS-Associated Mutation

Fay, J. M., Zhu, C., Proctor, E. A., Tao, Y., Cui, W., Ke, H. & Dokholyan, N. V., Nov 1 2016, In : Structure. 24, 11, p. 1898-1906 9 p.

Research output: Contribution to journalArticle

Amyotrophic Lateral Sclerosis
Cell Survival
Mutation
Poisons
Motor Neurons
21 Citations (Scopus)

A photonic crystal cavity-optical fiber tip nanoparticle sensor for biomedical applications

Shambat, G., Rajasekhar Kothapalli, S., Khurana, A., Provine, J., Sarmiento, T., Cheng, K., Cheng, Z., Harris, J., Daldrup-Link, H., Sam Gambhir, S. & Vuković, J., May 21 2012, In : Applied Physics Letters. 100, 21, 213702.

Research output: Contribution to journalArticle

optical fibers
photonics
nanoparticles
cavities
sensors
9 Citations (Scopus)

A physical model reveals the mechanochemistry responsible for Dynein's processive motion

Tsygankov, D., Serohijos, A. W. R., Dokholyan, N. & Elston, T. C., Jul 6 2011, In : Biophysical journal. 101, 1, p. 144-150 7 p.

Research output: Contribution to journalArticle

Dyneins
Stroke
Head
Microtubules
Binding Sites
5 Citations (Scopus)

A pixel pitch-matched ultrasound receiver for 3-d photoacoustic imaging with integrated delta-sigma beamformer in 28-nm UTBB FD-SOI

Chen, M. C., Pena Perez, A., Kothapalli, S-R., Cathelin, P., Cathelin, A., Gambhir, S. S. & Murmann, B., Nov 1 2017, In : IEEE Journal of Solid-State Circuits. 52, 11, p. 2843-2856 14 p., 8068946.

Research output: Contribution to journalArticle

Photoacoustic effect
Ultrasonics
Pixels
Imaging techniques
Beamforming
11 Citations (Scopus)

ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations

Williams, B., Convertino, M., Das, J. & Dokholyan, N. V., Jan 1 2015, In : PLoS computational biology. 11, 10, e1004359.

Research output: Contribution to journalArticle

Apolipoprotein E4
Alzheimer's Disease
molecular dynamics
Molecular Dynamics Simulation
Alzheimer disease
202 Citations (Scopus)

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists

Zhang, W. B., Navenot, J. M., Haribabu, B., Tamamuraz, H., Hiramatu, K., Omagari, A., Pei, G., Manfredi, J. P., Fujii, N., Broach, J. & Peiper, S. C., Jul 5 2002, In : Journal of Biological Chemistry. 277, 27, p. 24515-24521 7 p.

Research output: Contribution to journalArticle

Point Mutation
Viperidae
Computer aided manufacturing
Pheromone Receptors
Yeasts
119 Citations (Scopus)

Apoptosis: Molecules and mechanisms

Konopleva, M., Zhao, S., Xie, Z., Segall, H., Younes, A., Claxton, D., Estrov, Z., Kornblau, S. M. & Andreeff, M., Dec 1 1999, In : Advances in experimental medicine and biology. 457, p. 217-236 20 p.

Research output: Contribution to journalArticle

Apoptosis
Modulators
Molecules
Effector Caspases
Caspase 1
38 Citations (Scopus)

Apoptosis and angiogenesis in cancer prevention by selenium

Lu, J., Aug 7 2001, In : Advances in Experimental Medicine and Biology. 492, p. 131-145 15 p.

Research output: Contribution to journalArticle

Selenium
Antineoplastic Agents
Rats
Animals
Antioxidants
250 Citations (Scopus)

Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase

Wang, H. G., Miyashita, T., Takayama, S., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., Troppmair, J., Rapp, U. R. & Reed, J. C., Sep 1 1994, In : Oncogene. 9, 9, p. 2751-2756 6 p.

Research output: Contribution to journalArticle

Proto-Oncogene Proteins c-raf
Apoptosis
Sf9 Cells
Proteins
Baculoviridae
462 Citations (Scopus)

Apoptotic and autophagic cell death induced by histone deacetylase inhibitors

Shao, Y., Gao, Z., Marks, P. A. & Jiang, X., Dec 28 2004, In : Proceedings of the National Academy of Sciences of the United States of America. 101, 52, p. 18030-18035 6 p.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Autophagy
Caspases
Cell Death
Butyrates
1 Citation (Scopus)

A possible role for platelet-activating factor receptor in amyotrophic lateral sclerosis treatment

Briones, M. R. S., Snyder, A., Ferreira, R. C., Neely, E. B., Connor, J. & Broach, J., Feb 6 2018, In : Frontiers in Neurology. 9, FEB, 39.

Research output: Contribution to journalArticle

Amyotrophic Lateral Sclerosis
Platelet Activating Factor
ginkgolide B
Interleukin-18
WEB 2086
8 Citations (Scopus)
Nuclear Envelope
Phenobarbital
Cytochrome P-450 Enzyme System
Endoplasmic Reticulum
Thioacetamide
107 Citations (Scopus)

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: A multi-center study

Pope, W. B., Qiao, X. J., Kim, H. J., Lai, A., Nghiemphu, P., Xue, X., Ellingson, B. M., Schiff, D., Aregawi, D., Cha, S., Puduvalli, V. K., Wu, J., Yung, W. K. A., Young, G. S., Vredenburgh, J., Barboriak, D., Abrey, L. E., Mikkelsen, T., Jain, R., Paleologos, N. A. & 5 others, Rn, P. L., Prados, M., Goldin, J., Wen, P. Y. & Cloughesy, T., Jul 1 2012, In : Journal of neuro-oncology. 108, 3, p. 491-498 8 p.

Research output: Contribution to journalArticle

Glioblastoma
Disease-Free Survival
Survival
Bevacizumab
Normal Distribution

Appearance of cutaneous malignancies of the head and neck

Andrews, G. A., Anderson, B. & Neves, R., Mar 1 2013, In : Operative Techniques in Otolaryngology - Head and Neck Surgery. 24, 1, p. 2-8 7 p.

Research output: Contribution to journalArticle

Neck
Head
Merkel Cell Carcinoma
Skin
Basal Cell Carcinoma
5 Citations (Scopus)

Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building

Sherer, E. A., Sale, M. E., Pollock, B. G., Belani, C., Egorin, M. J., Ivy, P. S., Lieberman, J. A., Manuck, S. B., Marder, S. R., Muldoon, M. F., Scher, H. I., Solit, D. B. & Bies, R. R., Aug 1 2012, In : Journal of Pharmacokinetics and Pharmacodynamics. 39, 4, p. 393-414 22 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Genetic Models
Population
Datasets
3 Citations (Scopus)

Application of Chemical Principles in the Solution Synthesis and Processing of Ceramic and Metal Particles

Adair, J. H., Kerchner, J. A., Bell, N. S. & Carasso, M. L., Dec 1 1998, In : ACS Symposium Series. 681, p. 82-94 13 p.

Research output: Contribution to journalArticle

Powders
Phase stability
Metals
Processing
Calcium Oxalate

Application of non-myeloablative allogeneic stem cell transplantation to solid tumors

Mineishi, S., 2001, In : Biotherapy. 15, 4, p. 461-466 6 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Neoplasms
Weapons
Whole-Body Irradiation
Immunosuppressive Agents
7 Citations (Scopus)

Application of population dynamics to study heterotypic cell aggregations in the near-wall region of a shear flow

Ma, Y., Wang, J., Liang, S., Dong, C. & Du, Q., Mar 1 2010, In : Cellular and Molecular Bioengineering. 3, 1, p. 3-19 17 p.

Research output: Contribution to journalArticle

Cell Aggregation
Population dynamics
Population Dynamics
Shear flow
Shear Flow
23 Citations (Scopus)

Application of the dual-micropipet technique to the measurement of tumor cell locomotion

You, J., Mastro, A. M. & Dong, C., Apr 10 1999, In : Experimental Cell Research. 248, 1, p. 160-171 12 p.

Research output: Contribution to journalArticle

Cell Movement
Pseudopodia
Neoplasms
Melanoma
Pressure
Open Access
lungs
inhibitors
therapy
Microscopic examination
cancer
2 Citations (Scopus)

Applications of statistical physics to the oil industry: Predicting oil recovery using percolation theory

King, P. R., Buldyrev, S. V., Dokholyan, N., Havlin, S., Lee, Y., Paul, G., Stanley, H. E. & Vandesteeg, N., Jan 1 2001, In : Petroleum Geoscience. 7, p. S105-S117

Research output: Contribution to journalArticle

Scaling laws
Oil fields
oil industry
oil field
aid
2 Citations (Scopus)

Applying a high-Throughput fluorescence polarization assay for the discovery of chemical probes blocking La:RNA interactions in vitro and in cells

Sommer, G., Fedarovich, A., Kota, V., Rodriguez, R., Smith, C. D. & Heise, T., Mar 2017, In : PloS one. 12, 3, e0173246.

Research output: Contribution to journalArticle

Fluorescence Polarization
Assays
Fluorescence
Throughput
fluorescence